top of page

THE PULSE

What's top of mind for you with the FDA?

Leadership: Will Acting Commissioner Kyle Diamantas be confirmed, will a new nominee emerge, or will the compressed Congressional calendar push a permanent pick into next year?
Innovation posture: Over the next two years, will the FDA continue its pro-innovator trajectory, or will sponsors face greater scrutiny and delay?
FDA-CMS alignment: Will FDA and CMS make meaningful progress working more closely together to give innovators greater regulatory clarity?
User fee programs: Will PDUFA and MDUFA implementation stay on track over the next year?

We are asking our JKS and WHIC community a single question — always at the intersection of health policy and politics, and always the kind of question Washington insiders are already debating.

​

Your responses will be kept completely confidential — we'll only share aggregated results with our JKS client and WHIC member community. No individual answers, no attribution, ever. Our team thinks the results will be genuinely interesting, and we'll share them in our newsletter.

© 2025 JK Strategies, Public Affairs LLC

601 13th Street NW, 12th Floor, Washington D.C., 20005

Designed by Loft Creative Co.

bottom of page